β-arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation

Molecular and Cellular Biology

Volumn 31, Issue 5, 2011, Pages 1066-1075

  Anthony, D F ^a   Sin, Y Y ^a   Vadrevu, S ^a   Advant, N ^a   Day, J P ^a   Byrne, A M ^a   Lynch, M J ^a   Milligan, G ^a   Houslay, M D ^a   Baillie, G S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; BETA ARRESTIN 1; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN SYNTHESIS INHIBITION; SCREENING; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

AMINO ACID SEQUENCE; ARRESTINS; CELLS, CULTURED; GTPASE-ACTIVATING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; RECEPTOR, ANGIOTENSIN, TYPE 1; RHOA GTP-BINDING PROTEIN; STRESS FIBERS;

EID: 79952265050     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00883-10     Document Type: Article

References (43)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Atienza, J. M., et al. 2006. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev. Technol. 4:597-607.
3. Baillie, G. S., et al. 2007. Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of β-arrestin using spot-immobilized peptide arrays. Biochem. J. 404:71-80. (Pubitemid 46788086)
4. Barnes, W. G., et al. 2005. β-Arrestin 1 and Gαq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J. Biol. Chem. 280:8041-8050.
5. Bassères, D. S., E. V. Tizzei, A. A. Duarte, F. F. Costa, and S. T. Saad. 2002. ARHGAP10, a novel human gene coding for a potentially cytoskeletal Rho-GTPase activating protein. Biochem. Biophys. Res. Commun. 294:579-585.
6. Bolger, G. B., et al. 2006. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, β-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem. J. 398:23-36. (Pubitemid 44231298)
7. Borges, L., et al. 2008. ARHGAP21 associates with FAK and PKCζ and is redistributed after cardiac pressure overload. Biochem. Biophys. Res. Commun. 374:641-646.
8. + CML progenitor cells. Leukemia 21:1708-1714.
9. Carles, A., et al. 2006. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 25:1821-1831.
10. Claing, A., et al. 2001. β-Arrestin-mediated ADP-ribosylation factor 6 activation and β2-adrenergic receptor endocytosis. J. Biol. Chem. 276:42509-42513.
11. DeFea, K. A. 2007. Stop that cell! β-Arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu. Rev. Physiol. 69:535-560.
12. DeWire, S. M., S. Ahn, R. J. Lefkowitz, and S. K. Shenoy. 2007. β-Arrestins and cell signaling. Annu. Rev. Physiol. 69:483-510.
13. Dubois, T., and P. Chavrier. 2005. ARHGAP10, a novel RhoGAP at the cross-road between ARF1 and Cdc42 pathways, regulates Arp2/3 complex and actin dynamics on Golgi membranes. Med. Sci. (Paris) 21:692-694. (In French.)
14. Dubois, T., et al. 2005. Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics. Nat. Cell Biol. 7:353-364.
15. Ehlers, A., S. Stempin, R. Al-Hamwi, and A. Lampen. 2010. Embryotoxic effects of the marine biotoxin okadaic acid on murine embryonic stem cells. Toxicon 55:855-863.
16. Godin, C. M., and S. S. Ferguson. 2010. The angiotensin II type 1 receptor induces membrane blebbing by coupling to Rho A, Rho kinase, and myosin light chain kinase. Mol. Pharmacol. 77:903-911.
17. Higashi, M., et al. 2003. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93:767-775.
18. Hsu, H. H., et al. 2008. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J. Mol. Med. 86:1379-1394.
19. Jaffe, A. B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269.
20. James, S. E., et al. 2008. Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants. Neurotoxicology 29:605-612.
21. Katoh, M., and M. Katoh. 2004. Characterization of human ARHGAP10 gene in silico. Int. J. Oncol. 25:1201-1206.
22. Katoh, M., and M. Katoh. 2003. FNBP2 gene on human chromosome 1q32.1 encodes ARHGAP family protein with FCH, FBH, RhoGAP and SH3 domains. Int. J. Mol. Med. 11:791-797.
23. Kirstein, S. L., et al. 2006. Live cell quality control and utility of real-time cell electronic sensing for assay development. Assay Drug Dev. Technol. 4:545-553.
24. Kumari, S., and S. Mayor. 2008. ARF1 is directly involved in dynamin-independent endocytosis. Nat. Cell Biol. 10:30-41.
25. Legrain, P., and L. Selig. 2000. Genome-wide protein interaction maps using two-hybrid systems. FEBS Lett. 480:32-36.
26. Li, X., G. S. Baillie, and M. D. Houslay. 2009. Mdm2 directs the ubiquitination of β-arrestin-sequestered cAMP phosphodiesterase-4D5. J. Biol. Chem. 284:16170-16182.
27. Li, X., et al. 2009. A scanning peptide array approach uncovers association sites within the JNK/βarrestin signalling complex. FEBS Lett. 583:3310-3316.
28. Lu, Q., F. M. Longo, H. Zhou, S. M. Massa, and Y. H. Chen. 2009. Signaling through Rho GTPase pathway as viable drug target. Curr. Med. Chem. 16:1355-1365.
29. Ménétrey, J., et al. 2007. Structural basis for ARF1-mediated recruitment of ARHGAP21 to Golgi membranes. EMBO J. 26:1953-1962. (Pubitemid 46624047)
30. Meng, D., et al. 2009. MEK1 binds directly to βarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization. J. Biol. Chem. 284:11425-11435.
31. Meshki, J., et al. 2009. Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism. J. Biol. Chem. 284:9280-9289.
32. Nakamura, A., et al. 2003. Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. J. Vasc. Res. 40:244-251.
33. Rajagopal, S., K. Rajagopal, and R. J. Lefkowitz. 2010. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9:373-386.
34. Ryan, M. J., S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund. 2004. Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension 43:1074-1079.
35. Shenoy, S. K., and R. J. Lefkowitz. 2005. Seven-transmembrane receptor signaling through β-arrestin. Sci. STKE 2005:cm10.
36. Smith, K. J., et al. 2007. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, β-arrestin and RACK1. Cell. Signal. 19:2612-2624.
37. Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153-208.
38. Urcan, E., et al. 2010. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent. Mater. 26:51-58.
39. Vincent, S., and J. Settleman. 1999. Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization. Eur. J. Cell Biol. 78:539-548.
40. Violin, J. D., and R. J. Lefkowitz. 2007. β-Arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28:416-422.
41. Vistejnova, L., et al. 2009. The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. Neuro Endocrinol. Lett. 30(Suppl. 1):121-127.
42. Wei, H., et al. 2003. Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 100:10782-10787.
43. Yu, N., et al. 2006. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal. Chem. 78:35-43.